Vanguard Group
BCLI

Vanguard Group’s BRAINSTORM CELL THERAPUTC BCLI Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$31.1K Hold
27,724
﹤0.01% 4223
2025
Q1
$34.9K Sell
27,724
-50,717
-65% -$63.9K ﹤0.01% 4218
2024
Q4
$178K Sell
78,441
-1,432,199
-95% -$3.25M ﹤0.01% 4117
2024
Q3
$347K Hold
1,510,640
﹤0.01% 4051
2024
Q2
$511K Buy
1,510,640
+109,647
+8% +$37.1K ﹤0.01% 3994
2024
Q1
$791K Sell
1,400,993
-22,317
-2% -$12.6K ﹤0.01% 3886
2023
Q4
$389K Hold
1,423,310
﹤0.01% 4104
2023
Q3
$285K Hold
1,423,310
﹤0.01% 4193
2023
Q2
$2.93M Sell
1,423,310
-5,223
-0.4% -$10.8K ﹤0.01% 3531
2023
Q1
$4.71M Hold
1,428,533
﹤0.01% 3333
2022
Q4
$2.34M Buy
1,428,533
+631
+0% +$1.04K ﹤0.01% 3606
2022
Q3
$6.31M Hold
1,427,902
﹤0.01% 3198
2022
Q2
$3.94M Buy
1,427,902
+6,803
+0.5% +$18.8K ﹤0.01% 3503
2022
Q1
$4.78M Sell
1,421,099
-9,473
-0.7% -$31.8K ﹤0.01% 3551
2021
Q4
$5.72M Sell
1,430,572
-1,847
-0.1% -$7.39K ﹤0.01% 3531
2021
Q3
$4.73M Buy
1,432,419
+19,593
+1% +$64.7K ﹤0.01% 3699
2021
Q2
$5.37M Buy
1,412,826
+82,374
+6% +$313K ﹤0.01% 3558
2021
Q1
$5.1M Buy
1,330,452
+35,364
+3% +$135K ﹤0.01% 3521
2020
Q4
$5.86M Buy
1,295,088
+93,245
+8% +$422K ﹤0.01% 3287
2020
Q3
$20.3M Sell
1,201,843
-154,233
-11% -$2.61M ﹤0.01% 2451
2020
Q2
$15.2M Buy
1,356,076
+139,804
+11% +$1.57M ﹤0.01% 2554
2020
Q1
$5.64M Buy
1,216,272
+444,204
+58% +$2.06M ﹤0.01% 2920
2019
Q4
$3.3M Buy
772,068
+5,200
+0.7% +$22.3K ﹤0.01% 3302
2019
Q3
$2.99M Buy
766,868
+75,122
+11% +$293K ﹤0.01% 3308
2019
Q2
$2.73M Hold
691,746
﹤0.01% 3380
2019
Q1
$3M Buy
691,746
+5,140
+0.7% +$22.3K ﹤0.01% 3329
2018
Q4
$2.44M Sell
686,606
-7,625
-1% -$27.1K ﹤0.01% 3313
2018
Q3
$2.65M Hold
694,231
﹤0.01% 3439
2018
Q2
$2.71M Buy
694,231
+14,200
+2% +$55.4K ﹤0.01% 3408
2018
Q1
$2.14M Buy
680,031
+1,264
+0.2% +$3.98K ﹤0.01% 3436
2017
Q4
$2.66M Buy
678,767
+1,191
+0.2% +$4.67K ﹤0.01% 3337
2017
Q3
$2.79M Buy
677,576
+20,475
+3% +$84.3K ﹤0.01% 3306
2017
Q2
$2.73M Buy
657,101
+17,657
+3% +$73.4K ﹤0.01% 3289
2017
Q1
$2.72M Buy
639,444
+58,287
+10% +$248K ﹤0.01% 3280
2016
Q4
$1.48M Buy
581,157
+10,390
+2% +$26.4K ﹤0.01% 3460
2016
Q3
$1.36M Buy
570,767
+78,900
+16% +$189K ﹤0.01% 3499
2016
Q2
$1.19M Buy
491,867
+6,200
+1% +$15K ﹤0.01% 3559
2016
Q1
$1.3M Buy
485,667
+22,627
+5% +$60.4K ﹤0.01% 3525
2015
Q4
$1.32M Buy
463,040
+12,897
+3% +$36.9K ﹤0.01% 3540
2015
Q3
$1.03M Buy
450,143
+31,946
+8% +$73.2K ﹤0.01% 3619
2015
Q2
$1.51M Buy
418,197
+95,045
+29% +$343K ﹤0.01% 3534
2015
Q1
$1.44M Buy
+323,152
New +$1.44M ﹤0.01% 3526